UK markets close in 5 hours 43 minutes

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.2100+0.0400 (+3.42%)
At close: 04:00PM EDT
1.1600 -0.05 (-4.13%)
After hours: 07:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 150.91M
Enterprise value 56.79M
Trailing P/E 9.72
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.96
Price/book (mrq)1.29
Enterprise value/revenue 1.56
Enterprise value/EBITDA 3.01

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 3-48.51%
S&P500 52-week change 3-5.62%
52-week high 32.9300
52-week low 30.3010
50-day moving average 31.1989
200-day moving average 31.2986

Share statistics

Avg vol (3-month) 35.32M
Avg vol (10-day) 31.26M
Shares outstanding 5116.98M
Implied shares outstanding 6N/A
Float 850.03M
% held by insiders 10.05%
% held by institutions 180.03%
Shares short (28 Jul 2022) 44.8M
Short ratio (28 Jul 2022) 41.89
Short % of float (28 Jul 2022) 4N/A
Short % of shares outstanding (28 Jul 2022) 44.10%
Shares short (prior month 29 Jun 2022) 45.89M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 34.90%
Operating margin (ttm)-57.42%

Management effectiveness

Return on assets (ttm)-13.82%
Return on equity (ttm)34.85%

Income statement

Revenue (ttm)36.46M
Revenue per share (ttm)0.34
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)18.56M
EBITDA -20.86M
Net income avi to common (ttm)12.72M
Diluted EPS (ttm)0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)94.3M
Total cash per share (mrq)0.81
Total debt (mrq)16.76M
Total debt/equity (mrq)19.05
Current ratio (mrq)7.92
Book value per share (mrq)0.75

Cash flow statement

Operating cash flow (ttm)-5.24M
Levered free cash flow (ttm)-6.7M